Please login to the form below

Not currently logged in
Email:
Password:

specialty care

This page shows the latest specialty care news and features for those working in and with pharma, biotech and healthcare.

Sanofi warns of difficult few months as diabetes sales slump

Sanofi warns of difficult few months as diabetes sales slump

Furthermore, with the consolidation of Bioverativ and the acquisition of Ablynx, we have established the foundation for a global rare blood disorder franchise which will further enhance our leadership in specialty ... care, ”he added.

Latest news

  • Third time lucky? Sanofi cuts an $11.6bn deal to buy Bioverativ Third time lucky? Sanofi cuts an $11.6bn deal to buy Bioverativ

    In a statement the French pharma group’s chief executive - Olivier Brandicourt - said the deal “enhances its presence in specialty care and leadership in rare diseases”and will make the company ... While there is a lot of excitement about the

  • Choices, choices... Choices, choices...

    This has important practical implications. The capabilities needed to succeed with an incrementally innovative small molecule in primary-care, for example, are quite different from those needed to succeed with a ... discontinuously innovative large

  • Sanofi Genzyme launches multiple sclerosis awareness campaign Sanofi Genzyme launches multiple sclerosis awareness campaign

    The specialty care unit of Sanofi aims to highlight and address the often debilitating symptoms through its vs.MS campaign by encouraging people living with MS to “ declare themselves” online. ... employment. Greater than 50% of care partners

  • Digital roundup Digital roundup

    Sanofi's specialty care business Genzyme has been rebranded as Sanofi Genzyme, and the unit took the opportunity to join Facebook.

  • Daiichi Sankyo cuts a swathe through US workforce Daiichi Sankyo cuts a swathe through US workforce

    business away from primary care and towards specialty drugs in the "cardiovascular, pain management and oncology" categories.

More from news
Approximately 0 fully matching, plus 29 partially matching documents found.

Latest Intelligence

  • Accelerating innovation Accelerating innovation

    We beat, if you will, the standard of care, ”said Alexandre, adding: “We are superior to sunitinib, which has been on the market for 10 years.”The study also showed evidence ... The mindset has changed. We are becoming a global biotech company that

  • A rare talent A rare talent

    Prior to this he held a number of roles at Astellas, most recently as specialty care director for the UK business, and country manager, for Finland, where he established the

  • Forging a path in specialty care Forging a path in specialty care

    Forging a path in specialty care. Takeda’ s Marc Princen on the company’ s plans to build a reputation in oncology, gastroenterology and vaccine. ... We've already made key appointments in these areas and we're still recruiting for new talent who

  • Delivering accessible healthcare Delivering accessible healthcare

    the principles of self-diagnosis, self-care and self-pay. ... As pharmaceutical companies increasingly focus on specialty care, products that can meet a mass-market medical need are becoming scarce.

  • Building a business that is lean and specialised Building a business that is lean and specialised

    He says that although Celgene is expanding, by continuing to focus on specialty products the company doesn't need hundreds of sales representatives and can continue to be lean. ... If you talk about the promotional part of market, specialty care

More from intelligence
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

  • It's time to change the conversation

    Connecting to patients, care givers and advocacy groups has become more important for some diseases. ... Although MS is considered a specialty disease and therefore treated with specialty drugs, it is in fact marketed as a primary care (RRMS), specialty

  • Streaming Well

    The team take particular time and care in their work to provide contributors with the help they need to make high-quality communications materials, and it's a pleasure (I might ... care. "Streaming Well maintain upmost professionalism particularly when

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech,...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics